Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Roger S. Lo
Based on 48 articles published since 2010
(Why 48 articles?)
||||
Expertise Level
The expertise of Roger S. Lo ranks in the
  • Top 0.51%
  • ... of 120,378 published authors worldwide on Melanoma
  • ... from 2010 through 2020
  • ... based on contributions to 48 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Lo, Roger S   ·   Lo, Roger   ·   Lo, R S
Work Locations
Details
Most likely:    UCLA   Contact    
2019
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Medical Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Experimental Pharmacology Unit, Department of Translational Research, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA. · Department of Pathology and Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · The Angeles Clinic, Experimental Therapeutics Cedars Sinai Foundation, Los Angeles, CA, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · University of Chicago Medical Center, Chicago, IL, USA. · Oncology Department, UNIL-CHUV, Lausanne, Switzerland. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Institut de Cancérologie, Gustave Roussy Cancer Campus, Villejuif, Paris, France. · Refuge Biotechnologies, Menlo Park, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, 9609 Medical Center Drive, Bethesda, MD, 20892-7420, USA. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Pubmed 31331337
2018
  • Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Department of Biostatistics, Gillings School of Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Division of Hematology/Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Division of Surgical Oncology, Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Melanoma Program, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Department of Dermatology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Department of Cell Biology & Physiology, Histology Research Core Facility, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Division of Dermatology, Department of Medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Queensland Institute of Medical Research-QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, United States. · Pubmed 30662871
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Medicine, The University of California, Los Angeles, Los Angeles, California. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 29496759
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, California. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California. · David Geffen School of Medicine, University of California, Los Angeles, California. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California. · Huntsman Cancer Institute and Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, Utah. · Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, California. · Pubmed 28923912
2017
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, California. · David Geffen School of Medicine, University of California, Los Angeles, California. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California. · Department of Surgery, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, California. · Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, California. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, California. · Pubmed 28864476
  • Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA. Electronic address: · Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA. · Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA; Division of Translational Oncology, Carlos III Health Institute, 28029 Madrid, Spain. · Division of Dermatology, Department of Medicine, UCLA, Los Angeles, CA 90095, USA. · Statistics Core, Department of Medicine, UCLA, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA 90095, USA; Crump Institute for Molecular Imaging, UCLA, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095, USA. · Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095, USA; Division of Surgical Oncology, Department of Surgery, UCLA, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA 90095, USA; California NanoSystems Institute, UCLA, Los Angeles, CA 90095, USA. · Division of Dermatology, Department of Medicine, UCLA, Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095, USA. · Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095, USA; Division of Surgical Oncology, Department of Surgery, UCLA, Los Angeles, CA 90095, USA. Electronic address: · Pubmed 28494868
  • University of California, Los Angeles (UCLA), Los Angeles, California. · Jonsson Comprehensive Cancer Center, Los Angeles, California. · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland. · University of California, Los Angeles (UCLA), Los Angeles, California. · Pubmed 27903500
2016
  • Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Crump Institute for Molecular Imaging, University of California Los Angeles, Los Angeles, CA, USA. · Division of Dermatology, Department of Medicine, University of California Los Angeles , Los Angeles, CA, USA. · Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles , Los Angeles, CA, USA. · Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Division of Surgical-Oncology, Department of Surgery, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA. · Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Division of Dermatology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA. · Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Crump Institute for Molecular Imaging, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA; California NanoSystems Institute, University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 27648299
  • From the University of California, Los Angeles (UCLA) (J.M.Z., A.G.-D., D.S.S., H.E.-O., W.H., S.H.-L., D.Y.T., G.A.-R., S.S., L.B., J.S., B.H.M., B.C., K.R., I.P.S., P.J.S., C.P.-S., G.C., E.S., X.K., J.P., B.B.-M., B.C.-A., T.G.G., P.C.T., R.S.L., A.R.), and Jonsson Comprehensive Cancer Center (B.C., B.C.-A., T.G.G., P.C.T., R.S.L., A.R.) - both in Los Angeles · and the Division of Immunology, Netherlands Cancer Institute, Amsterdam (R.M., T.N.M.S.). · Pubmed 27433843
  • Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Departments of Dermatology and Pathology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Developmental Therapeutics, Cancer Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Medicine and Dermatology, University of Arizona Cancer Center, Tucson, AZ, USA. · Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA. · Department of Dermatology, Knight Cancer Institute Melanoma and Skin Cancer Program, Oregon Health Science University, Portland, OR, USA. · Molecular Oncology Program, Melanoma Laboratory, CNIO, Madrid, Spain. · Department of Dermatology, Huntsman Cancer Institute, Salt Lake City, UT, USA. · Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. · Department of Dermatology, Stanford University Medical Center and Cancer Institute/VA Palo Alto Health Care System, Palo Alto, CA, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Department of Dermatology and Dermatopathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Dermatology, University of Zurich, Zürich, Switzerland. · Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Melanoma and Skin Cancer Program, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Pathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Medical Oncology and Dermatology, University of California Los Angeles, Los Angeles, CA, USA. · Melanoma Institute, University of Sydney, Sydney, NSW, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical School, Nashville, TN, USA. · Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Women Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Program, Department of Dermatology, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Melanoma and Pigmented Lesion Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Dermatology, University of Bonn, Bonn, Germany. · Melanoma Research Foundation, Washington, DC, USA. · Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. · Pubmed 27087480
  • The Wistar Institute, Philadelphia, Pennsylvania 19104, USA. · University of the Sciences, Philadelphia, Pennsylvania 19104, USA. · Department of Dermatology, University of Zurich, Zurich CH-8006, Switzerland. · The National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA. · Department of Dermatology and Pathology, Yale University, New Haven, Connecticut 06511, USA. · Massachusetts General Hospital Cancer Center, Developmental Therapeutics, Boston 02114, Massachusetts, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, Texas 77030, USA. · Departments of Surgery and Pathology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. · Department of Medical Oncology, City of Hope Medical Center, Duarte, California 91010, USA. · Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, California 90095, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead 2145, Australia. · Melanoma Institute Australia and The University of Sydney, Sydney 2000, Australia. · Department of Medicine, Vanderbilt University Medical Center, Nashville Tennessee 37232, USA. · Department of Dermatology, University Hospital, West German Cancer Center, University Duesburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Heidelberg 45127, Germany. · Pubmed 27042933
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Department of Surgery, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. Electronic address: · Pubmed 26997480
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
2015
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA. Electronic address: · Pubmed 26359985
  • NantOmics LLC, Santa Cruz, CA 95060; · Samsung Advanced Institute of Technology, Suwon-si, Gyeonggi-do, 443-803, Korea; · Department of Statistics, University of California, Berkeley, CA 94720-3860; · Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health Sciences University, Portland, OR 97239; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; · Department of Medical and Molecular Genetics, Oregon Health & Science University, Portland, OR 97239-30; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; Royal Prince Alfred Hospital, The University of Sydney, Camperdown, NSW 2050, Australia; · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; · Department of Hematology and Oncology, University of California, San Francisco, CA 94143-1770; · Samsung Electronics, Inc. Seocho-gu, Seoul 137-857, Korea; · Department of Dermatology, University of California, San Francisco, CA 94115; · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Pathology, University of California, San Francisco, CA 94143-0511 · Pubmed 26286987
  • Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Division of Dermatology/Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095-1662, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095-1662, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Animal Tumor Model Program, Division of Comparative Medicine, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Division of Dermatology/Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095-1662, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095-1662, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Pubmed 26139106
  • Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · 1] Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA [2] Gerstner Sloan Kettering School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · 1] Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA [2] MRC Cancer Unit, University of Cambridge, Cambridge CB2 0XZ, UK. · Division of Dermatology, Department of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California 90095, USA. · 1] Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA [2] Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · Pubmed 25807485
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Division of Oncology, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. · Discovery Oncology, Merck Research Laboratories, Boston, MA 02115, USA. · Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Radiological Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Medicine, Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK. · Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA 94143, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: · Pubmed 25600339
  • Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Translational Molecular Pathology, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Departments of Pathology and Laboratory Medicine and Surgery, David Geffen School of Medicine at University of California Los Angeles (UCLA), John Wayne Cancer Institute, Santa Monica, CA, USA. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · University of Manchester/Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre and University of Melbourne, Victoria, Australia. · Department of Oncology-Pathology, The Karolinska Hospital, Stockholm, Sweden. · Centro de Investigación Médica Aplicada, and Clinica Universidad de Navarra, Pamplona, Navarra, Spain. · Department of Dermatology, Harvard Medical School, Boston, MA, USA. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Division of Molecular Oncology, Unit of Bio-Immunotherapy of Solid Tumors, San Raffaele Institute, Milan, Italy. · Vanderbilt University Medical Center, Nashville, TN, USA. · Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Essen, Germany. · Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Centre, Doha, Qatar. · INSERM, UMRS1138, Laboratory of Integrative Cancer Immunology, Université Paris Descartes, Sorbonne Paris Cité, Centre de Recherche des Cordeliers, Paris, France. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 26619946
2014
  • Division of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Division of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, University of California, Los Angeles (UCLA), 10833 Le Conte Avenue, Los Angeles, California 90095-1750, USA. · Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles (UCLA), 10833 Le Conte Avenue, Los Angeles, California 90095-7227, USA. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Headington, Oxford OX3 7DQ, UK. · Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge CB10 1SA, UK. · 1] Division of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, University of California, Los Angeles (UCLA), 10833 Le Conte Avenue, Los Angeles, California 90095-1750, USA [2] UCLA Metabolomics Center, Crump Institute for Molecular Imaging, California Nanosystems Institute, UCLA, 570 Westwood Plaza, Building 114, Los Angeles, California 90095-7227, USA [3] Jonsson Comprehensive Cancer Center (JCCC), 8-684 Factor Building, Los Angeles, California 90095-1781, USA. · 1] Division of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, University of California, Los Angeles (UCLA), 10833 Le Conte Avenue, Los Angeles, California 90095-1750, USA [2] Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles (UCLA), 10833 Le Conte Avenue, Los Angeles, California 90095-7227, USA [3] Jonsson Comprehensive Cancer Center (JCCC), 8-684 Factor Building, Los Angeles, California 90095-1781, USA. · Pubmed 25502142
  • Department of Medicine (Division of Hematology-Oncology), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Surgery (Division of Surgical-Oncology), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Department of Surgery (Division of Surgical-Oncology), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · The Paterson Institute, Manchester, UK. · Department of Medicine (Division of Dermatology), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. Electronic address: · Department of Medicine (Division of Hematology-Oncology), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Surgery (Division of Surgical-Oncology), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. Electronic address: · Pubmed 24345644
  • Division of Dermatology, Department of Medicine. · David Geffen School of Medicine, University of California, LA, California 90095-1662 USA. · Department of Molecular and Medical Pharmacology. · Division of Surgical Oncology, Department of Surgery. · Division of Hematology & Oncology, Department of Medicine. · Department of Medicine. · Vanderbilt-Ingram Cancer Center, Nashville, TN 37232. · Department of Cancer Biology. · Department of Surgery. · Melanoma Institute of Australia, Westmead Millenium Institute, Westmead Hospital, University of Sydney, New South Wales, Australia. · Jonsson Comprehensive Cancer Center. · Ludwig Institute for Cancer Research, Brussels Branch, Belgium. · Pubmed 24265155
  • Department of Medicine, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. · Pubmed 24258979
2013
  • Department of Medicine, Division of Dermatology, David Geffen School of Medicine, University of California, Jonsson Comprehensive Cancer Center, Los Angeles, California 90095, USA. · Pubmed 23318787
  • · Pubmed 23551976
2012
  • Division of Dermatology, Department of Medicine, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, 52-121 CHS, 10833 Le Conte Ave, Los Angeles, CA 90095-1750, USA. · Pubmed 22565288
2014
  • 1Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, 2Translational Research Laboratory, Cancer Therapeutics Program, 3Bioinformatics Core Facility, 4The Cancer Signalling Laboratory, Oncogenic Signaling and Growth Control Program, 5Gene Regulation Laboratory, Cancer Therapeutics Program, 6Molecular Imaging and Targeted Therapeutics Laboratory, Cancer Therapeutics Program, 7Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne; 8Sir Peter MacCallum Department of Oncology, Departments of 9Biochemistry and Molecular Biology, and 10Pathology, University of Melbourne, Parkville; 11Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Waurn Ponds; 12Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria; 13Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; 14Department of Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital; 15Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; 16Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and 17Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. · Pubmed 24469106
  • 1The Division of Dermatology, Department of Medicine, 2Division of Surgical Oncology, Department of Surgery, 3Division of Hematology and Oncology, Department of Medicine, 4Jonsson Comprehensive Cancer Center, 5Department of Molecular and Medical Pharmacology, 6David Geffen School of Medicine, University of California, Los Angeles, California; 7Melanoma Institute of Australia, 8Royal Prince Alfred Hospital, 9Westmead Millennium Institute, and 10Westmead Hospital, University of Sydney, New South Wales, Australia. · Pubmed 24265152
2013
  • Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, University of California, Los Angeles, Los Angeles, CA 90095-1770, USA. · Pubmed 23436302
2012
  • Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California 90095-1750, USA. · Pubmed 22588879
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, 52-121 CHS, 10833 Le Conte Avenue, California 90095-1750, USA. · Pubmed 22395615
2011
  • Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, United States of America. · Pubmed 22194965
  • Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. · Pubmed 21803746
  • Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles (UCLA), USA. · Pubmed 21609436
2010
  • Division of Dermatology/Department of Medicine, UCLA's Jonsson Comprehensive Cancer Center, 52-121 CHS, Los Angeles, California 90095-1750, USA. · Pubmed 21107323
  • Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 20406486
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 48 total) written by Roger S. Lo about Melanoma:

  • Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy). 2019
  • The Prognostic Significance of Low-Frequency Somatic Mutations in Metastatic Cutaneous Melanoma. 2018
  • The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression. 2018
  • High-Speed Live-Cell Interferometry: A New Method for Quantifying Tumor Drug Resistance and Heterogeneity. 2018
  • Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma. 2018
  • Recurrent Tumor Cell-Intrinsic and -Extrinsic Alterations during MAPKi-Induced Melanoma Regression and Early Adaptation. 2017
  • Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression. 2017
  • Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations. 2017
  • JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma. 2016
  • Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma. 2016
Show List of Full Article Records
Google Searches

Learn more about Roger S. Lo using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
UCLA
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
UCLA
2019
  • Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Medical Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Experimental Pharmacology Unit, Department of Translational Research, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Department of Melanoma Medical Oncology, Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology, University of Zurich Hospital, Zurich, Switzerland. · Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, USA. · Department of Pathology and Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medicine, Chicago, IL, USA. · Division of Dermatologic Oncology, Department of Dermatology, Eberhard Karls University, Tuebingen, Germany. · The Angeles Clinic, Experimental Therapeutics Cedars Sinai Foundation, Los Angeles, CA, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. · University of Chicago Medical Center, Chicago, IL, USA. · Oncology Department, UNIL-CHUV, Lausanne, Switzerland. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Institut de Cancérologie, Gustave Roussy Cancer Campus, Villejuif, Paris, France. · Refuge Biotechnologies, Menlo Park, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Division of Surgery of Melanoma and Skin Cancer, Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale", Naples, Italy. · Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, 9609 Medical Center Drive, Bethesda, MD, 20892-7420, USA. · Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. · Pubmed 31331337
2018
  • Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Department of Biostatistics, Gillings School of Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Division of Hematology/Oncology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Division of Surgical Oncology, Department of Surgery, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Melanoma Program, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Department of Dermatology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Department of Cell Biology & Physiology, Histology Research Core Facility, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. · Division of Dermatology, Department of Medicine, Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, United States. · Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia. · Queensland Institute of Medical Research-QIMR Berghofer Medical Research Institute, Herston, QLD, Australia. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, United States. · Pubmed 30662871
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Medicine, The University of California, Los Angeles, Los Angeles, California. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 29496759
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, California. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California. · David Geffen School of Medicine, University of California, Los Angeles, California. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California. · Huntsman Cancer Institute and Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, Utah. · Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, California. · Pubmed 28923912
2017
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, California. · David Geffen School of Medicine, University of California, Los Angeles, California. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, California. · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California. · Department of Surgery, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee. · Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, California. · Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, California. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, California. · Pubmed 28864476
  • Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA. Electronic address: · Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA. · Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA; Division of Translational Oncology, Carlos III Health Institute, 28029 Madrid, Spain. · Division of Dermatology, Department of Medicine, UCLA, Los Angeles, CA 90095, USA. · Statistics Core, Department of Medicine, UCLA, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA 90095, USA; Crump Institute for Molecular Imaging, UCLA, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095, USA. · Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095, USA; Division of Surgical Oncology, Department of Surgery, UCLA, Los Angeles, CA 90095, USA. · Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA 90095, USA; California NanoSystems Institute, UCLA, Los Angeles, CA 90095, USA. · Division of Dermatology, Department of Medicine, UCLA, Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095, USA. · Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095, USA; Division of Surgical Oncology, Department of Surgery, UCLA, Los Angeles, CA 90095, USA. Electronic address: · Pubmed 28494868
  • University of California, Los Angeles (UCLA), Los Angeles, California. · Jonsson Comprehensive Cancer Center, Los Angeles, California. · Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland. · University of California, Los Angeles (UCLA), Los Angeles, California. · Pubmed 27903500
2016
  • Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Crump Institute for Molecular Imaging, University of California Los Angeles, Los Angeles, CA, USA. · Division of Dermatology, Department of Medicine, University of California Los Angeles , Los Angeles, CA, USA. · Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles , Los Angeles, CA, USA. · Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Division of Hematology-Oncology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Division of Surgical-Oncology, Department of Surgery, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA. · Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Division of Dermatology, Department of Medicine, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA. · Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, CA, USA; Crump Institute for Molecular Imaging, University of California Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA; California NanoSystems Institute, University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 27648299
  • From the University of California, Los Angeles (UCLA) (J.M.Z., A.G.-D., D.S.S., H.E.-O., W.H., S.H.-L., D.Y.T., G.A.-R., S.S., L.B., J.S., B.H.M., B.C., K.R., I.P.S., P.J.S., C.P.-S., G.C., E.S., X.K., J.P., B.B.-M., B.C.-A., T.G.G., P.C.T., R.S.L., A.R.), and Jonsson Comprehensive Cancer Center (B.C., B.C.-A., T.G.G., P.C.T., R.S.L., A.R.) - both in Los Angeles · and the Division of Immunology, Netherlands Cancer Institute, Amsterdam (R.M., T.N.M.S.). · Pubmed 27433843
  • Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Departments of Dermatology and Pathology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Developmental Therapeutics, Cancer Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Medicine and Dermatology, University of Arizona Cancer Center, Tucson, AZ, USA. · Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA. · Department of Dermatology, Knight Cancer Institute Melanoma and Skin Cancer Program, Oregon Health Science University, Portland, OR, USA. · Molecular Oncology Program, Melanoma Laboratory, CNIO, Madrid, Spain. · Department of Dermatology, Huntsman Cancer Institute, Salt Lake City, UT, USA. · Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. · Department of Dermatology, Stanford University Medical Center and Cancer Institute/VA Palo Alto Health Care System, Palo Alto, CA, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Department of Dermatology and Dermatopathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Dermatology, University of Zurich, Zürich, Switzerland. · Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Melanoma and Skin Cancer Program, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Pathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Medical Oncology and Dermatology, University of California Los Angeles, Los Angeles, CA, USA. · Melanoma Institute, University of Sydney, Sydney, NSW, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical School, Nashville, TN, USA. · Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Women Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Program, Department of Dermatology, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Melanoma and Pigmented Lesion Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Dermatology, University of Bonn, Bonn, Germany. · Melanoma Research Foundation, Washington, DC, USA. · Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. · Pubmed 27087480
  • The Wistar Institute, Philadelphia, Pennsylvania 19104, USA. · University of the Sciences, Philadelphia, Pennsylvania 19104, USA. · Department of Dermatology, University of Zurich, Zurich CH-8006, Switzerland. · The National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA. · Department of Dermatology and Pathology, Yale University, New Haven, Connecticut 06511, USA. · Massachusetts General Hospital Cancer Center, Developmental Therapeutics, Boston 02114, Massachusetts, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, Texas 77030, USA. · Departments of Surgery and Pathology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. · Department of Medical Oncology, City of Hope Medical Center, Duarte, California 91010, USA. · Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, California 90095, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead 2145, Australia. · Melanoma Institute Australia and The University of Sydney, Sydney 2000, Australia. · Department of Medicine, Vanderbilt University Medical Center, Nashville Tennessee 37232, USA. · Department of Dermatology, University Hospital, West German Cancer Center, University Duesburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Heidelberg 45127, Germany. · Pubmed 27042933
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Department of Surgery, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; Division of Hematology & Oncology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, CA 90095-1662, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, CA 90095-1662, USA. Electronic address: · Pubmed 26997480
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
2015
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA. · Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095-1662, USA. Electronic address: · Pubmed 26359985
  • NantOmics LLC, Santa Cruz, CA 95060; · Samsung Advanced Institute of Technology, Suwon-si, Gyeonggi-do, 443-803, Korea; · Department of Statistics, University of California, Berkeley, CA 94720-3860; · Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health Sciences University, Portland, OR 97239; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; · Department of Medical and Molecular Genetics, Oregon Health & Science University, Portland, OR 97239-30; · Melanoma Institute Australia, Crows Nest, NSW 1585, Australia; Royal Prince Alfred Hospital, The University of Sydney, Camperdown, NSW 2050, Australia; · Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; · Department of Hematology and Oncology, University of California, San Francisco, CA 94143-1770; · Samsung Electronics, Inc. Seocho-gu, Seoul 137-857, Korea; · Department of Dermatology, University of California, San Francisco, CA 94115; · Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065; · Department of Pathology, University of California, San Francisco, CA 94143-0511 · Pubmed 26286987
  • Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Division of Dermatology/Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095-1662, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095-1662, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Animal Tumor Model Program, Division of Comparative Medicine, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Division of Dermatology/Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095-1662, USA. · Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095-1662, USA. · Department of Cancer Biology, Beckman Research Institute of City of Hope Cancer Center, Duarte, CA, 91010, USA. · Pubmed 26139106
  • Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · 1] Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA [2] Gerstner Sloan Kettering School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · 1] Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA [2] MRC Cancer Unit, University of Cambridge, Cambridge CB2 0XZ, UK. · Division of Dermatology, Department of Medicine and Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California 90095, USA. · 1] Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA [2] Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520, USA. · Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA. · Pubmed 25807485
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Division of Oncology, Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. · Discovery Oncology, Merck Research Laboratories, Boston, MA 02115, USA. · Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Radiological Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Department of Medicine, Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK. · Department of Cancer Biology, Vanderbilt University, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA; Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN 37232, USA. · Division of Hematology and Oncology, University of California, San Francisco, San Francisco, CA 94143, USA. · Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. · Division of Dermatology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA 90095, USA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA. Electronic address: · Pubmed 25600339
  • Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Translational Molecular Pathology, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Departments of Pathology and Laboratory Medicine and Surgery, David Geffen School of Medicine at University of California Los Angeles (UCLA), John Wayne Cancer Institute, Santa Monica, CA, USA. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · University of Manchester/Christie NHS Foundation Trust, Manchester, UK. · Peter MacCallum Cancer Centre and University of Melbourne, Victoria, Australia. · Department of Oncology-Pathology, The Karolinska Hospital, Stockholm, Sweden. · Centro de Investigación Médica Aplicada, and Clinica Universidad de Navarra, Pamplona, Navarra, Spain. · Department of Dermatology, Harvard Medical School, Boston, MA, USA. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Division of Molecular Oncology, Unit of Bio-Immunotherapy of Solid Tumors, San Raffaele Institute, Milan, Italy. · Vanderbilt University Medical Center, Nashville, TN, USA. · Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland. · Department of Dermatology, University Hospital, West German Cancer Center, University Duisburg-Essen, Essen, Germany. · German Cancer Consortium (DKTK), Essen, Germany. · Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Centre, Doha, Qatar. · INSERM, UMRS1138, Laboratory of Integrative Cancer Immunology, Université Paris Descartes, Sorbonne Paris Cité, Centre de Recherche des Cordeliers, Paris, France. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Sidra Medical and Research Centre, Doha, Qatar. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 26619946
2014
  • Division of Molecular Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Division of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, University of California, Los Angeles (UCLA), 10833 Le Conte Avenue, Los Angeles, California 90095-1750, USA. · Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles (UCLA), 10833 Le Conte Avenue, Los Angeles, California 90095-7227, USA. · Division of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands. · Ludwig Institute for Cancer Research, Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Headington, Oxford OX3 7DQ, UK. · Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge CB10 1SA, UK. · 1] Division of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, University of California, Los Angeles (UCLA), 10833 Le Conte Avenue, Los Angeles, California 90095-1750, USA [2] UCLA Metabolomics Center, Crump Institute for Molecular Imaging, California Nanosystems Institute, UCLA, 570 Westwood Plaza, Building 114, Los Angeles, California 90095-7227, USA [3] Jonsson Comprehensive Cancer Center (JCCC), 8-684 Factor Building, Los Angeles, California 90095-1781, USA. · 1] Division of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, University of California, Los Angeles (UCLA), 10833 Le Conte Avenue, Los Angeles, California 90095-1750, USA [2] Department of Medicine, David Geffen School of Medicine at University of California, Los Angeles (UCLA), 10833 Le Conte Avenue, Los Angeles, California 90095-7227, USA [3] Jonsson Comprehensive Cancer Center (JCCC), 8-684 Factor Building, Los Angeles, California 90095-1781, USA. · Pubmed 25502142
  • Department of Medicine (Division of Hematology-Oncology), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Surgery (Division of Surgical-Oncology), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Department of Surgery (Division of Surgical-Oncology), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · The Paterson Institute, Manchester, UK. · Department of Medicine (Division of Dermatology), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. Electronic address: · Department of Medicine (Division of Hematology-Oncology), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Surgery (Division of Surgical-Oncology), David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. Electronic address: · Pubmed 24345644
  • Division of Dermatology, Department of Medicine. · David Geffen School of Medicine, University of California, LA, California 90095-1662 USA. · Department of Molecular and Medical Pharmacology. · Division of Surgical Oncology, Department of Surgery. · Division of Hematology & Oncology, Department of Medicine. · Department of Medicine. · Vanderbilt-Ingram Cancer Center, Nashville, TN 37232. · Department of Cancer Biology. · Department of Surgery. · Melanoma Institute of Australia, Westmead Millenium Institute, Westmead Hospital, University of Sydney, New South Wales, Australia. · Jonsson Comprehensive Cancer Center. · Ludwig Institute for Cancer Research, Brussels Branch, Belgium. · Pubmed 24265155
  • Department of Medicine, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. · Pubmed 24258979
2013
  • Department of Medicine, Division of Dermatology, David Geffen School of Medicine, University of California, Jonsson Comprehensive Cancer Center, Los Angeles, California 90095, USA. · Pubmed 23318787
  • · Pubmed 23551976
2012
  • Division of Dermatology, Department of Medicine, Jonsson Comprehensive Cancer Center, David Geffen School of Medicine, University of California, Los Angeles, 52-121 CHS, 10833 Le Conte Ave, Los Angeles, CA 90095-1750, USA. · Pubmed 22565288
2014
  • 1Molecular Oncology Laboratory, Oncogenic Signaling and Growth Control Program, 2Translational Research Laboratory, Cancer Therapeutics Program, 3Bioinformatics Core Facility, 4The Cancer Signalling Laboratory, Oncogenic Signaling and Growth Control Program, 5Gene Regulation Laboratory, Cancer Therapeutics Program, 6Molecular Imaging and Targeted Therapeutics Laboratory, Cancer Therapeutics Program, 7Department of Cancer Imaging, Peter MacCallum Cancer Centre, East Melbourne; 8Sir Peter MacCallum Department of Oncology, Departments of 9Biochemistry and Molecular Biology, and 10Pathology, University of Melbourne, Parkville; 11Metabolic Remodelling Laboratory, Metabolic Research Unit, School of Medicine, Deakin University, Waurn Ponds; 12Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria; 13Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead; 14Department of Tissue Pathology & Diagnostic Oncology, Royal Prince Alfred Hospital; 15Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; 16Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah; and 17Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California. · Pubmed 24469106
  • 1The Division of Dermatology, Department of Medicine, 2Division of Surgical Oncology, Department of Surgery, 3Division of Hematology and Oncology, Department of Medicine, 4Jonsson Comprehensive Cancer Center, 5Department of Molecular and Medical Pharmacology, 6David Geffen School of Medicine, University of California, Los Angeles, California; 7Melanoma Institute of Australia, 8Royal Prince Alfred Hospital, 9Westmead Millennium Institute, and 10Westmead Hospital, University of Sydney, New South Wales, Australia. · Pubmed 24265152
2013
  • Department of Molecular and Medical Pharmacology, Crump Institute for Molecular Imaging, University of California, Los Angeles, Los Angeles, CA 90095-1770, USA. · Pubmed 23436302
2012
  • Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, California 90095-1750, USA. · Pubmed 22588879
  • Division of Dermatology, Department of Medicine, University of California, Los Angeles, 52-121 CHS, 10833 Le Conte Avenue, California 90095-1750, USA. · Pubmed 22395615
2011
  • Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, California, United States of America. · Pubmed 22194965
  • Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, USA. · Pubmed 21803746
  • Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles (UCLA), USA. · Pubmed 21609436
2010
  • Division of Dermatology/Department of Medicine, UCLA's Jonsson Comprehensive Cancer Center, 52-121 CHS, Los Angeles, California 90095-1750, USA. · Pubmed 21107323
  • Department of Medicine, Division of Hematology/Oncology, University of California Los Angeles, Los Angeles, CA, USA. · Pubmed 20406486
Unspecified
2014
  • Division of Dermatology, Department of Medicine. · David Geffen School of Medicine, University of California, LA, California 90095-1662 USA. · Department of Molecular and Medical Pharmacology. · Division of Surgical Oncology, Department of Surgery. · Division of Hematology & Oncology, Department of Medicine. · Department of Medicine. · Vanderbilt-Ingram Cancer Center, Nashville, TN 37232. · Department of Cancer Biology. · Department of Surgery. · Melanoma Institute of Australia, Westmead Millenium Institute, Westmead Hospital, University of Sydney, New South Wales, Australia. · Jonsson Comprehensive Cancer Center. · Ludwig Institute for Cancer Research, Brussels Branch, Belgium. · Pubmed 24265155
23 Other Locations Show
Yearly article counts 01436766942
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.